Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.